Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-B5A4CD79
EviCore by Evernorth
Effective: February 15, 2019
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Epidural adhesiolysis (catheter or endoscopic) is considered experimental, investigational, and unproven for treatment of back pain and is therefore excluded from coverage; CPT codes 62263, 62264, 62280, 62281, and 62282 are specifically listed as experimental/investigational. No covered indications, prior‑authorization criteria, or specific documentation requirements are provided in the guideline due to insufficient scientific evidence.
Coverage Criteria Preview
Key requirements from the full policy
"There is insufficient scientific evidence to support the use of epidural adhesiolysis, performed by catheter or endoscopically, as a treatment for back pain. It is considered experimental, investig..."
Sign up to see full coverage criteria, indications, and limitations.